PHARMA
Astellas & Cancer Research UK Team Up In Fight Against Cancer
The partnership between Astellas and Cancer Research Technology will begin with the development of drugs for pancreatic cancer targeting autophagy.
Baxter Expands Biologics In Singapore
Baxter's biologic facility in Singapore has been approved by the European Medicines Agency to supply products for hemophiliacs.
Solasia Acquires License For ZIOPHARM’s Darinaparsin
ZIOPHARM could receive up to US$72.2 million from Solasia for the anti-cancer drug darinaparsin.
Merck To Open Second Largest Plant In China
Merck has invested US$134 million in China over the last three years, including the Nantong facility which will be their second largest plant globally.
Gilead Allows India & China To Produce Generic HIV/HBV Drug
An agreement with the Medicines Patent Pool allows generics manufacturers in India and China to produce Gilead's HBV and HIV drug, tenofovir alafenamide.
CEL-SCI’s Phase III Trial Enrols Patients From Sri Lanka
CEL-SCI has begun enrolling patients from Sri Lanka for a Phase III trial for Multikine, an investigational treatment for head and neck cancer.
Luye Raises US$764 Million With Hong Kong IPO
Luye Pharma has raised US$764 million through an IPO on the Main Board of the Stock Exchange of Hong Kong.
Phase I Trial For BeiGene’s PARP Inhibitor Begins
BeiGene's PARP inhibitor BGB-290 could be an important treatment for common cancers such as gastric cancer and primary brain tumors.
Sanofi & Takeda Partner For Diabetes
The partnership between Sanofi and Takeda aims to raise diabetes awareness and provide educational support for both patients and healthcare professionals.
